Bladder Cancer
Kidney Cancer
EAU Edu Platform on Prostate Cancer
Home
Articles
Article of the Month
Editorial
Videos
Webcasts
Education
Curriculum: mPCa patients treatment
Curriculum: CVD risk in PCa patients
E-courses
ESOU Online
Webinars
Guidelines
Events
Home
Articles
Terug
Article of the Month
Editorial
Videos
Webcasts
Education
Terug
Curriculum: mPCa patients treatment
Curriculum: CVD risk in PCa patients
E-courses
ESOU Online
Webinars
Guidelines
Events
Upcoming event
40th Annual EAU Congress
Home
/
Webcasts
Back
EMUC2024
ERUS2024
UROonco2024
EAU 2023
EMUC 22
EAU 2022
PCa21
ESU Masterclasses
ESOU21
EMUC20
EAU 20
ESOU20
EMUC 19
PCa2019
EAU 19
ESOU19
Filter
Tags
Abiraterone
,
Active surveillance
,
Adjuvant
,
ADT
,
Advanced prostate cancer
,
Alkaline phosphatase
,
Alternative splicing
,
Androgen
,
Androgen deprivation therapy
,
Androgen pathway blockade
,
Androgen receptor inhibitor
,
Antiandrogens
,
Anticancer agents
,
ARCHES
,
Article of the Month
,
ASCO GU21
,
ASCO GU22
,
ASCO21
,
AUA21
,
BHC80
,
Biochemical recurrence
,
Biomarkers
,
Biopsy
,
Bisphosphonates
,
Bone metastases
,
BRCA1
,
BRCA2
,
Castrate-resistanter
,
Castration-resistant
,
Chemotherapy
,
Clinical trial
,
Clinical trials
,
Cohort study
,
COVID-19
,
cSP
,
Deferred treatment
,
Diagnosis
,
Disease progression
,
Docetaxel
,
EAU21
,
EAU22
,
Emission-computed
,
EMUC21
,
EMUC22
,
End-to-side nerve grafting
,
Enzalutamide
,
Erectile dysfunction
,
Erectile function
,
ESMO21
,
ESMO22
,
ESOU Online
,
ESU Masterclass
,
ESU Masterclasses
,
External beam radiotherapy
,
Focal therapy
,
Frozen section
,
Fusion biopsies
,
Genomic classifier
,
Genomics
,
Guidelines
,
hormone-sensitive
,
HORRAD
,
HRQL
,
Image guided biopsy
,
Imaging
,
Immunohistochemistry
,
Index lesion
,
Indocyanine green
,
Intensity-modulated radiotherapy
,
Local radiotherapy
,
Localised
,
Localized
,
Localized prostate cancer
,
Lymph node excision
,
Lymphadenectomy
,
Mapping
,
Mass spectrometry
,
Masterclass
,
Masterclasses
,
MDV3100
,
Membranous urethra
,
Meta-analysis
,
Metastasis
,
Metastasized
,
Metastatic
,
Mortality reduction
,
mp-MRI
,
MRI
,
Neoplasm staging
,
Nerve sparing
,
Next-generation sequencing
,
Nomogram
,
Noncastrate
,
Orchiectomy
,
Overdiagnosis
,
p53
,
Patient information
,
PCa21
,
Penile rehabilitation
,
PET/CT
,
Positron emission tomography
,
Precision medicine
,
Pretreatment risk stratification
,
Pretreatment tables
,
Primary tumor treatment
,
Prognosis
,
Prognostic model
,
Prostasomes
,
Prostate screening
,
Prostate-specific antigen
,
Prostate-specific membrane antigen
,
Prostatic neoplasms
,
ProtecT trial
,
Proteomics
,
PSA
,
PSA flare
,
PSA kinetics
,
PSA screening
,
PSMA PET/CT
,
PTEN
,
Quality of life
,
Radiation therapy
,
Radical prostatectomy
,
Randomized prospective trial
,
Randomized trial
,
Randomized trials
,
Rapid metastasis
,
Rb
,
RB1
,
Receptors
,
Risk stratification
,
RNA splicing
,
Robotic prostatectomy
,
Robotic surgery
,
Robotic Urology
,
Robotics
,
Salvage therapy
,
Screening
,
Sentinel lymph node
,
Sexual quality of life
,
SREs
,
SRRM4
,
STAMPEDE
,
Stereotactic body radiotherapy
,
Surgical margins
,
Surgical video
,
Surgical videos
,
Systematic biopsy
,
Systematic review
,
Targeted Biopsy
,
TITAN
,
TP53
,
Transcriptome
,
Transperineal template biopsy
,
Tumor suppressor genes
,
Ultrasensitive PSA
,
Urinary incontinence
,
Urological surgery
,
Urowebinar
,
WCRF/AICR CUP
,
Webinar
,
Wnt
,
Zoledronic acid
Show all
Genetic testing for prostate cancer: When and how?
Watch now
Risk stratification based on targeted biopsies
Watch now
Basics of MRI
Watch now
Ultrasound is improving 29 Mhz, mpUS, C-TRUS, Elastography and microbubbles
Watch now
Tumour mutation testing: When and how?
Watch now
PSMA based imaging in primary and recurrent disease
Watch now
Timing of radiotherapy after radical prostatectomy
Watch now
Cryotherapy focal ablation
Watch now
A peek into the future: Artificial intelligence and prostate cancer imaging
Watch now
Update on Guidelines Prostate Cancer: What is new?
Watch now
Surgical margins and nerve sparing: The role of NeuroSafe
Watch now
State of the art: PSMA-treatment as it stands now: Why, who and when
Watch now
Previous
Next